La Jolla, CA USA

Our News on Newswise
View All >

La Jolla Institute for Immunology Launches New International Research Partnership with Link Campus University

La Jolla Institute for Immunology (LJI) and Link Campus University of Rome, Italy, and have signed a collaborative agreement as part of a strategic program aimed at promoting scientific research and innovation between the United States and Italy.
19-Nov-2024 12:25 PM EST Add to Favorites

Newswise: 66e9f13ace3a3_NucleocapsidSaphire2024.png

LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives

The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA—At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only...
17-Sep-2024 5:05 PM EDT Add to Favorites

T cells may offer some protection in an H5N1 'spillover' scenario

The LJI team uncovered important similarities between H5N1 and these common viruses, which allowed them to predict that many people already have "cross-reactive" T cells that are ready to target H5N1—should it ever mutate to cause widespread...
16-Sep-2024 1:05 PM EDT Add to Favorites

LJI Selected as Member of ARPA-H Investor Catalyst Hub Spoke Network

La Jolla Institute for Immunology (LJI) has been selected as a spoke for the Investor Catalyst Hub, a regional hub of ARPANET-H, a nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).
11-Sep-2024 12:05 PM EDT Add to Favorites

LJI scientists lead new mpox research

Scientists at La Jolla Institute for Immunology (LJI) are investigating how the mutated clade 1 mpox virus may affect children and older patients—and how new vaccines can help the body fight back.
22-Aug-2024 1:05 PM EDT Add to Favorites

Newswise: 667442d84d4f8_Sydney-Ramirez2020.jpg

Sydney Ramirez receives prestigious Burroughs Wellcome Fund Career Award

"As an infectious diseases clinician, I've always been focused on research into pathogen-host interactions. We need to know why some people get sicker than others."
20-Jun-2024 10:05 AM EDT Add to Favorites

New research points to 'stem-like' T cells as culprits in ulcerative colitis

The researchers hope to one day target this T cell population via drug therapy. "These cells may be a very important target for treating ulcerative colitis and perhaps other autoimmune diseases..."
18-Jun-2024 12:00 PM EDT Add to Favorites

Newswise: 665dfb5c1f1df_AyRaofeatured.png

LJI scientists develop new method to match genes to their molecular ‘switches’

LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have developed a new computational method for linking molecular marks on our DNA to gene activity. Their work may help researchers connect genes to the molecular “switches”...
3-Jun-2024 1:05 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: 67210e2064d2c_JSLJIISujanShresta00004-1.jpg

Update: San Diego scientist available to comment on dengue vaccine research — following report of second locally transmitted dengue case

29-Oct-2024 12:25 PM EDT

Newswise: 6707f40b890cb_JSLJIISujanShresta00004.jpg

Expert Alert: San Diego Scientist Available to Comment on Local Dengue Case

10-Oct-2024 11:05 AM EDT

Newswise: 66c7663a16335_SetteAlba.png

San Diego scientists available to discuss mutated mpox strain

22-Aug-2024 12:05 PM EDT

Expert available to discuss Lassa virus and antibody therapies against the virus

26-Nov-2019 10:40 AM EST

Newswise: MatthiasvonHerrath.png

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and...
12-Dec-2018 11:05 AM EST

See All Experts

Our YouTube Videos
View All >

About

The La Jolla Institute for Immunology is dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand our understanding of how the immune system works and to discover the causes of immune system disorders. The knowledge gained through our biomedical research can, in turn lead to the prevention, treatment and cure of a wide range of human diseases.

Experts

Facebook

close
0.31894